ISA 102

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameISA 102
Drug Alias NameCancer vaccine p53 - ISA PharmaceuticalP53 Synthetic Long Peptides VaccineP53-SLP vaccineISA-102
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIsa Pharmaceuticals Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Medical Center GroningenIsa Pharmaceuticals BvLeiden University Medical Center
Active IndicationsN/A
Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A